Abstract
2′-Deoxyribonolactone (dL) is a C1′-oxidized abasic site damage generated by a radical attack on DNA. Numerous genotoxic agents have been shown to produce dL including UV and γ-irradiation, ene-dye antibiotics etc. At present the biological consequences of dL present in DNA have been poorly documented, mainly due to the lack of method for introducing the lesion in oligonucleotides. We have recently designed a synthesis of dL which allowed investigation of the mutagenicity of dL in Escherichia coli by using a genetic reversion assay. The lesion was site-specifically incorporated in a double-stranded bacteriophage vector M13G*1, which detects single-base-pair substitutions at position 141 of the lacZα gene by a change in plaque color. In E.coli JM105 the dL-induced reversion frequency was 4.7 × 10–5, similar to that of the classic abasic site 2′-deoxyribose (dR). Here we report that a dL residue in a duplex DNA codes mainly for thymidine. The processing of dL in vivo was investigated by measuring lesion-induced mutation frequencies in DNA repair deficient E.coli strains. We showed a 32-fold increase in dL-induced reversion rate in AP endonuclease deficient (xth nfo) mutant compared with wild-type strain, indicating that the Xth and Nfo AP endonucleases participate in dL repair in vivo.
INTRODUCTION
2′-Deoxyribonolactone (dL) is one of the numerous oxidation products formed in DNA. The lesion is produced following radical hydrogen atom abstraction at the 1′ position of 2′-deoxyribose (1). This C1′-oxidized apurinic/apyrimidinic (AP) site has been reported to be produced through a variety of radical processes including the action of anticancer drugs [e. g. the neocarzinostatin chromophore which contains the enediyne residue (2–5)], heterocyclic N-oxides of the tirapazamine family (6,7), cationic manganese porphyrins (8,9), copper phenanthroline complex Cu(OP)2, a chemical nuclease (10–12), or γ-irradiation (13,14) and UV exposure (15–17). One of the main features of this abasic lesion resides in its alkali-labile sensitivity: the lactone leads to DNA strand scission by β and δ elimination processes (18–20) with formation of 5-methylene furanone as an ultimate product (8,10,21–23). For a long time this instability has been a limitation on knowledge of the chemistry and biological consequences of the lesion. To address the major questions concerning the specificity of its repair and its mutagenic potency, the disposal of short synthetic DNAs containing a single dL lesion is of prime importance. If very little is known about dL repair, it has been mainly due to the paucity of synthetic methods. In this context, our laboratory developed an efficient and general synthesis of oligodeoxyribonucleotides containing a dL lesion at a predetermined position in the sequence. This method is based on the use of a 7-nitroindole nucleotide (dNi) as a photo-active precursor of dL (20,24). The modified nucleoside dNi has a maximum absorption at 360 nm and illumination above 320 nm triggers a radical process where an intramolecular 1′-hydrogen abstraction is performed by the nitroindole moiety in its excited state, evolving quantitatively towards dL formation. It should be stressed that irradiation of DNA above 320 nm does not generate photodamage. Such a quantitative triggered method allows the production of oligonucleotide quantities for structural determination (25) and in vitro and in vivo biological studies. Other methods based on the photo-triggered formation of the dL lesion in short oligonucleotides have also been reported (11,15,16,26–31). Despite their lower selectivity and poorer yields, these methods enabled investigations on dL reactivity towards itself and certain DNA repair enzymes (19,32–34). Recently, a new approach based on the photoactivation of a nitroveratryl cyanohydrine motif to generate dL has also been described (35).
Our starting hypothesis in this study is based on the structural analogy between dL and 2′-deoxyribose, a regular abasic site, which suggests that the AP site-specific repair enzymes might be involved in dL repair. The AP site is an intermediate of the base excision repair (BER) pathway in which DNA glycosylases excise mispaired and/or modified bases (36,37). The AP site lacks a base and is potentially cytotoxic and/or mutagenic (38,39). This non-informative lesion can lead to nucleotide misincorporation during the replication and transcription processes (40–43). During processing of the abasic lesions by the BER pathway, the initial step involves AP endonucleases, which incise DNA at the 5′ position adjacent to the baseless site. Two major enzymes were identified in Escherichia coli: exonuclease III (Xth), which represents >80% of the total AP endonuclease activity in wild type (WT) (44), and endonuclease IV (Nfo), which accounts for 5–10% of the total AP-endonuclease activity (45,46). If the baseless lesion is refractory to excision repair, it may be encountered by DNA polymerases. Numerous in vitro and in vivo studies of baseless lesions in E.coli came up with the establishment of an ‘A rule’: when a DNA polymerase is confronted with a non-instructional lesion, it tends to insert the dAMP nucleotide opposite the lesion rather than any of the three other nucleotides (47,48). Nevertheless, this ‘A rule’ is not always strictly obeyed. For example, in mammalian cells, a random incorporation of nucleotide opposite 2′-deoxyribose has been found (49), whereas a dAMP was preferentially incorporated in human cells (50). In a previous study we have shown that the ‘A rule’ was obeyed for in vitro dL translesional synthesis by Klenow fragment exo– (51). Greenberg and colleagues (32) found that DNA substrates containing a dL lesion are cleaved by human Ape1 and can react with E.coli Nth (33), Fpg and human Nei-like protein 1 (hNEIL1) (34) to form DNA·protein covalent cross-links.
In the present study, we extended dL repair to a prokaryotic in vivo system using a bacteriophage-based genetic reversion assay in E.coli. Mutation frequencies and repair pathways for dL and its precursor 7-nitroindole (Ni) were determined and compared with those for 2′-deoxyribose (dR).
MATERIALS AND METHODS
Microbiological methods and E.coli strains
All bacterial genetic procedures were performed as described (52,53); these included manipulation with single-stranded filamentous bacteriophage vectors. Rich medium was LB broth, supplemented when required with 100 µg/ml ampicillin or 50 µg/ml kanamycin or 20 µg/ml chloramphenicol or 10 µg/ml tetracycline. M9 minimal medium was supplemented with thiamine. Electrocompetent E.coli strains were prepared as described (54). Fresh SOC medium was used as the incubation buffer following electroporation (53).
The E.coli strains and the plasmid used in this study are listed in Table 1. AB1157 derivatives containing the Tn10 insertions at specific sites in the genome were constructed by P1 transductions of the tetracycline resistance marker from the collection of strains for genetic mapping (55). The E.coli strains BH70F′, BH110F′ and BH160F′ were obtained by direct electrotransfer of plasmid pCJ105 (Cmr) from CJ236 to BH70, BH110 and BH160 strains as described (56). The transformants were selected on media containing two antibiotics: either kanamycin (10 µg/ml) + chloramphenicol (10 µg/ml) or tetracycline (5 µg/ml) + chloramphenicol (10 µg/ml). Phenotypes of all strains were verified on antibiotic selective media and by their ability to propagate the M13 bacteriophage. In addition, the phenotype of the BH110F′ strain was verified by plating on LB media containing methyl methanesulfonate at various concentrations (2–20 mM). Double-stranded M13G*1 DNA was a gift from Dr Lawrence A. Loeb (University of Washington, Seattle, WA) (57). Individual dark blue plaques were subcloned on top agar 1% containing ispropyl-β-d-thiogalactopyranoside, 5-bromo 4-chloro 3-indolyl β-d-galactoside (X-gal) and E.coli JM105 cells. An isolated dark blue plaque was grown in 3 ml LB for 12 h and single-stranded DNA was purified as described (53). The purity of the single-stranded DNA was verified by agarose gel electrophoresis.
Table 1. Bacterial strains.
| Strain | Genotypea | Origin | Source/reference |
|---|---|---|---|
| JM105 | [F′, traD36, proA+B+, lacIqΔ(lacZ)M15] endA, thi, rpsL (Strr), endA1, sbcB15 sbcC201 hsdR4 (rk–, mk+), Δ(lac-proAB) | Laboratory stock | |
| BH110F′ | nfo::Knr [Δ(xth-pncA)90 X::Tn10]/pCJ105 (Cmr) | AB1157 (BW528) | Present study |
| BH160F′ | nth::Knr [fpg::Knr X::Tn10]/pCJ105 (Cmr) | AB1157 (BW372) | Present study |
| BH70F′ | X::Tn10/pCJ105 (Cmr) | AB1157 | Present study |
| BH1100 | recA:Cmr | JM105 | Laboratory stock |
| BH430 | uvrA: Tetr | JM105 | Laboratory stock |
| CJ236 | dut1 ung1 thi1 relA1/pCJ105 (Cmr) | Laboratory stock |
aThe insertions X::Tn10 are the co-transducible tetracycline resistance markers with fpg or xth.
Enzymes
Purification of the E.coli Nfo (endonuclease IV) and UNG (uracil-DNA glycosylase) were performed as described (46,58). Molecular biology products, restriction endonucleases and T4 DNA ligase were purchased from Roche Diagnostics (Meylan, France). T4 polynucleotide kinase was purchased from New England BioLabs (OZYME, Saint-Quentin en Yvelines, France).
Oligonucleotides
Nitroindole nucleoside phosphoramidite was synthesized according to the method described (24). The structures of 2′-deoxyribonitroindole abasic site precursor, 2′-deoxyribonolactone and 2′-deoxyribose are illustrated in Figure 1. Phosphorylated 41mer oligonucleotide d(PO3-CTATTA CGCCAGCTGGXAAATGGGGGATGTGCTGCAAGGCG) complementary to positions 117–157 of the lacZ sequence, where X is 2′-deoxycytidine (dC) or 2′-deoxyguanosine (dG) or 2′-deoxyribonitroindole (dNi) or 2′-deoxyuridine (dU), were synthesized by the standard phosphoramidite method with a DNA synthesizer (Perceptive Biosystem 8900 DNA). Oligonucleotides were separated by denaturing 20% polyacrylamide gel electrophoresis (PAGE) and purified by elution from C18 column with a water–acetonitrile mixture (7/3) as described (53).
Figure 1.
Structure of the abasic lesions dL (2′-deoxyribonolactone) and dR (2′-deoxyribose) and of dNi (nitroindole precursor).
Construction of site-specifically modified double-stranded M13G*1
Construction of double-stranded M13G*1 vectors with site-specifically incorporated lesion precursors (dU or dNi) were performed as described (59). Briefly, 10 pmol of the synthetic 5′ phosphorylated 41mer oligonucleotide was hybridized to 0.2 µg single-stranded circular M13G*1 at a 25:1 primer-to-template ratio in 20 mM Tris–HCl, 10 mM MgCl2, 50 mM NaCl pH 7.5 buffer in a final volume of 10 µl. The solution was heated at 90°C for 3 min and then allowed to cool to 30°C before storage in an ice-water bath. The synthesis of the second strand was carried out by adding to the annealing reaction 3 U of T4 DNA polymerase, 3 U of T4 DNA ligase and 3 µl of 10× synthesis buffer containing 5 mM of each dNTP, 10 mM ATP, 100 mM Tris–HCl pH 7.5 and 20 mM dithiothreitol. The synthesis reaction was incubated in an ice bath for 5 min, then at 25°C for 5 min and finally at 37°C for 90 min. The reaction was stopped by adding 90 µl of TE buffer (10 mM Tris–HCl pH 8.0, 1 mM EDTA) at 4°C. The reaction products were analyzed on a 0.8% agarose gel containing 3 µg/ml ethidium bromide in TAE (40 mM Tris–acetate and 1 mM EDTA). The double-stranded DNA was desalted using a Sephadex G50 column (volume 1 ml). Aliquots (1–2 µl) of the desalted phage DNA were used directly for transformation. The blue revertant plaques were screened on media containing X-gal (40 µg/ml) and the nucleotide sequences of the phage DNA from the blue plaques were determined. A sample of M13G*1 containing a single dR residue was prepared by treating 20 ng of double-stranded circular M13G*1 containing a 2′-deoxyuridine at position141 with 1 nM of the UNG protein at 37°C for 60 min. The M13G*1 containing dL residue was prepared by illuminating the vector containing the nitroindole residue (dNi) at 365 nm for 14 h at 4°C. The illumination device used in this study was obtained from Fisher Bioblock Scientific (Fisher Scientific SAS, Elancourt Cedex, France) and consisted of an illumination tube and a filter that selected wavelengths ranging from 310 to 400 nm centered at 365 nm (the maximum absorption for dNi is 360 nm) with an energy of 7 mW/cm2. The illumination tube is guaranteed to be free from lower wavelengths (particularly 254 nm); under such conditions the main absorbing compound is the Ni residue, and DNA damage which requires more energetic radiations (260 nm for creating thymine dimers and <200 nm for generating reactive oxygen species) are excluded. The conversions dU→dR and dNi→dL was controlled by annealing the 32P-labeled modified primers with their complementary strand and treating the short duplexes with either 0.1 M NaOH at 37°C for 30 min or 100 nM Nfo at 37°C for 10 min. The alkali labile lesions and abasic site residues were then evidenced by denaturing PAGE. A sample of 10 ng of the lesion containing double-stranded M13G*1 phage was used to electroporate a 55 µl suspension of E.coli electrocompetent cells as described (54). Transformation mixtures were incubated in 900 µl of SOC medium at 37°C for 1 h followed by overnight incubation in 10 ml LB at 37°C. The double-stranded phage DNA was isolated using a Nucleospin-plasmid column (Macherey Nagel S.ar.l., Hoerdt, France). The presence and purity of M13G*1 DNA was controlled by agarose gel electrophoresis (0.8%, TAE buffer).
Lesion-induced reversion rate assay
Various strains of electrocompetent E.coli were transformed with double-stranded M13G*1 containing dR or dL or dNi followed by overnight incubation at 37°C with shaking. The centrifuged cultures containing about 1011 phage particles per millilitre were used for plating on media containing X-gal and E.coli JM105. After overnight incubation at 37°C, the dark blue plaques representing revertants were scored. Mutation frequency was calculated as the ratio of dark blue plaques to the total number of plaques. Three independent synthesis reactions were performed and five to seven independent transformations were carried out to determine mutation frequencies. The nucleotide sequence of the phage DNA from revertants was determined by dideoxy DNA sequencing using a Big-Dye terminator V3.1 cycle sequencing kit (ABI Applied Biosystems, France) according to the manufacturer’s instructions. Sequence reading was performed on a 3100 ABI Sequencor.
Altered restriction site mutagenesis
A 5′ phosphorylated primer d(CACAAACGAATGGATCT TCATTAAAGCCAGAATGC) containing a mutated BamHI restriction site (C replaced by T in bold type) and the primer containing dNi residue were co-hybridized with single-stranded M13G*1 phage. Primer elongation, vector ligation, precursor conversion, cell transformation, growth and phage DNA recovery were performed as described above. A resulting 5 µg of the double-stranded M13G*1 phage DNA progeny was incubated overnight at 37°C with 40 U of BamHI in the reaction buffer supplied by manufacturer and purified by ethanol precipitation. The BamHI-digested phage DNA was used to determine the mutation frequency.
RESULTS
Site-specific incorporation of dNi, dL and dR into M13G*1
We have designed a strategy allowing the introduction of dL in E.coli cells to study its mutagenic effect and its repair in vivo. The assay combines the use of a lesion precursor and the previously described bacteriophage-based genetic reversion assay. A bacteriophage vector M13G*1 detects single-base substitutions, namely X→C, T and A (where X is either a G or a modified residue) at position 141 of the lacZα gene by change from white-to-blue plaque color (57). To generate site-specifically modified circular duplex DNA containing G·C, C·C U·C and Ni·C base pairs at position 141, the 41mer oligonucleotides complementary to the 117–157 region of the single-stranded M13G*1, containing dG, dC, dU and dNi, respectively, were used as primers. About 90% of the 41mer primers were fully extended in the presence of T4 DNA polymerase, T4 DNA ligase and the dNTPs (data not shown). Alkaline and Nfo treatments were used to ascertain conversion of the dU and dNi precursors into dR and dL after UNG treatment and illumination, respectively. As shown in Figure 2, ≥95% of the dU- and dNi-containing oligonucleotide duplexes were resistant to the treatment, indicating the absence of abasic sites (Fig. 2, lanes 1, 6 and 7). Partial degradation of the dNi-oligonucleotide by excess Nfo is due to non-specific 3′-5′ exonuclease activity (Fig. 2, lane 6) (60). As expected, UNG-treated and UV-irradiated duplex oligonucleotides were cleaved by alkaline and Nfo (Fig. 2, lanes 3, 4, 9 and 10), indicating efficient formation of the abasic site residues. However, <8–10% of the non-converted dNi precursor remains under the illumination conditions used (Fig. 2, lanes 9 and 10), and ∼4–6% of dL undergoes spontaneous degradation by β and δ elimination (lane 8). The illumination and UNG treatment did not degrade the phage DNA and did not affect transformation efficiency (data not shown).
Figure 2.
Analysis of the 41mer oligonucleotides containing dU, dR, dNi and dL lesions by denaturing PAGE. Lanes 1,4,7 and 10, 300 nM NaOH for 30 min at 37°C; lanes 2,5 and 8, non-treated oligonucleotides; lanes 3,6 and 9, 100 nM Nfo for 10 min at 37°C. For details see Materials and Methods.
Analysis of the lesion-induced mutation frequencies in WT and mutant E.coli
A sufficient number of transformants (105–108 per microgram of DNA) to measure mutation frequency were obtained with the double-stranded phage M13G*1 containing dC·dC, dG·dC, dR·dC, dNi·dC and dL·dC nucleotide pairs. As expected, M13G*1 containing dC·dC mismatch induced blue plaques with high frequency (4 × 10–1). The photochemical treatment may produce small amounts of undesirable DNA damage which in turn could contribute to mutagenesis. To address this possibility we irradiated the double-stranded M13G*1 vector containing a dG·dC base pair at position 141 under the same conditions as for the vector containing the dNi residue at 365 nm for 14 h at 4°C. The irradiated M13G*1 containing dG·dC produced only colorless plaques in E.coli JM105 and no blue plaques were found among 60 000 plaques screened. These results strongly indicate that the photochemical treatment and in vitro primer synthesis did not induce mutations at a detectable level under the experimental conditions used. As shown in Tables 2–4, the presence of dR, dNi and dL lesions in M13G*1 induced reversion to blue plaques with frequencies ranging from 2.2 × 10–5 to 14 × 10–5 in WT E.coli strains AB1157 and/or JM105 proficient in DNA repair.
Table 2. Mutation frequencies from in vivo replication of site-specifically incorporated dL residue into M13G*1 phage DNA.
| Strain (genotype) | Ratio of no. of blue plaques to no. of screened plaques | Mutation frequency | Averagea | Ratio of mutant to WT |
|---|---|---|---|---|
| BH70F′ (WT) | (5.5 ± 5.6) × 10–5 | 1 | ||
| Ex.1 | 4/32 800 | 1.21 × 10–4 | ||
| Ex.2 | 1/31 200 | 3.2 × 10–5 | ||
| Ex.3 | 1/70 200 | 1.42 × 10–5 | ||
| BH110F′ (xth nfo) | (1.8 ± 1.1) × 10–3 | 32 | ||
| Ex.1 | 12/3240 | 3.7 × 10–3 | ||
| Ex.2 | 48/39 000 | 1.2 × 10–3 | ||
| Ex.3 | 10/5760 | 1.7 × 10–3 | ||
| Ex.4 | 6/5000 | 1.2 × 10–3 | ||
| Ex.5 | 1/1000 | 1 × 10–3 | ||
| BH160F′ (nth fpg) | (2.9 ± 3.1) × 10–4 | 5.3 | ||
| Ex.1 | 3/46 400 | 6.4 × 10–5 | ||
| Ex.2 | 11/16 800 | 6.5 × 10–4 | ||
| Ex.3 | 10/58 400 | 1.7 × 10–4 | ||
| JM105 (WT) | (5.7 ± 1.4) × 10–5 | 1 | ||
| Ex.1 | 1/13 550 | 7.3 × 10–5 | ||
| Ex.2 | 1/30 000 | 3.3 × 10–5 | ||
| Ex.3 | 2/31 000 | 6.4 × 10–5 | ||
| Ex.4 | 1/16 300 | 6 × 10–5 | ||
| Ex.5 | 2/30 200 | 6.6 × 10–5 | ||
| Ex.6 | 1/21 600 | 4.6 × 10–5 | ||
| BH430 (uvrA) | (3.3 ± 1.8) × 10–5 | 0.6 | ||
| Ex.1 | 1/20 400 | 5 × 10–5 | ||
| Ex.2 | 2/141 000 | 1.4 × 10–5 | ||
| Ex.3 | 1/29 600 | 3.4 × 10–5 | ||
| BH1100 (recA) | (2.5 ± 2.6) × 10–4 | 4.4 | ||
| Ex.1 | 9/15 900 | 5.6 × 10–4 | ||
| Ex.2 | 1/10 100 | 1 × 10–4 | ||
| Ex.3 | 1/10 000 | 1 × 10–4 |
aFrequency numbers are the average ± standard deviation of three to five independent experiments.
Table 4. Mutation frequencies from in vivo replication of site-specifically incorporated dNi residue into M13G*1 phage DNA.
| Strain (genotype) | Ratio of no. of blue plaques to no. of screened plaques | Mutation frequency | Averagea | Ratio of mutant to WT |
|---|---|---|---|---|
| BH70F′ (WT) | (1.4 ± 0.3) × 10–4 | 1 | ||
| Ex.1 | 4/39 200 | 1 × 10–4 | ||
| Ex.2 | 2/13 200 | 1.5 × 10–4 | ||
| Ex.3 | 6/38 200 | 1.6 × 10–4 | ||
| BH110F′ (xth nfo) | (3.2 ± 2) × 10–4 | 2.3 | ||
| Ex.1 | 36/315 000 | 1.1 × 10–4 | ||
| Ex.2 | 6/33 340 | 1.8 × 10–4 | ||
| Ex.3 | 13/30 300 | 4.3 × 10–4 | ||
| Ex.4 | 4/29 200 | 1.4 × 10–4 | ||
| Ex.5 | 1/2160 | 4.6 × 10–4 | ||
| Ex.6 | 4/6800 | 5.9 × 10–4 | ||
| BH160F′ (nth fpg) | (1.9 ± 1.5) × 10–4 | 1.3 | ||
| Ex.1 | 18/43 600 | 4.1 × 10–4 | ||
| Ex.2 | 6/45 200 | 1.3 × 10–4 | ||
| Ex.3 | 1/9900 | 1 × 10–4 | ||
| Ex.4 | 3/28 300 | 1 × 10–4 | ||
| JM105 (WT) | (2.2 ± 1.3) × 10–5 | 1 | ||
| Ex.1 | 4/351 600 | 1.1 × 10–5 | ||
| Ex.2 | 12/908 000 | 1.3 × 10–5 | ||
| Ex.3 | 2/46 400 | 4.3 × 10–5 | ||
| Ex.4 | 1/53 600 | 1.8 × 10–5 | ||
| Ex.5 | 2/84 000 | 2.4 × 10–5 | ||
| BH430 (uvrA) | 0 | ND | ||
| Ex.1 | 0/1000 | 0 | ||
| Ex.2 | 0/9000 | 0 | ||
| Ex.3 | 0/2000 | 0 | ||
| BH1100 (recA) | (2.3±1.0) × 10–4 | 10.6 | ||
| Ex.1 | 2/7400 | 2.7 × 10–4 | ||
| Ex.2 | 1/8100 | 1.2 × 10–4 | ||
| Ex.3 | 7/22 000 | 3.1 × 10–4 |
aFrequency numbers are the average ± standard deviation of three to five independent experiments.
In the present study, we used altered site mutagenesis (61) to select the dL-containing strand progeny. Two oligonucleotides, one containing dNi and the other containing a mutated BamHI restriction site, were used as primers to generate double-stranded M13G*1. The resulting M13G*1 with mutated BamHI site and dNi was UV-irradiated and used for the first round of transformation to E.coli BH70F′. The phage DNA from the transformants was then digested by BamHI and used for the second round of transformation, and the reversion frequencies in phage progeny from the first and second rounds of transformation were compared. Only a 2-fold increase in mutation frequency was found for the BamHI-mutated progeny [(1.0 ± 0.2) × 10–4] compared with the non-digested progeny [(5.5 ± 5.6) × 10–5].
To investigate the contribution of different DNA repair pathways to the elimination of dL, the modified M13G*1 was transformed into WT (AB1157 and/or JM105), AP endonuclease deficient (BH110F′), DNA glycosylase deficient (BH160F′), nucleotide excision repair (NER) deficient (BH430F′) and recombination deficient (BH1100) E.coli strains. As shown in Table 2, >30-fold higher mutation frequency was observed in BH110F′ strain compared with isogenic BH70F′ WT strain. Although a 5-fold higher mean mutation frequency was observed in BH160F′ and BH1100 strains compared with the respective WT strains, the differences were not statistically significant (p > 0.05). No detectable increase in reversion rate was observed in the BH430 strain compared with the isogenic WT JM105 strain.
The mutation frequencies induced by dR and dNi lesions in WT and mutant E.coli strains were also measured and compared with that of dL. As shown in Table 3, the dR-induced mutation frequencies in BH110F′, BH160F′ and BH1100F′ were only 3–5-fold higher than those in WT strains, suggesting that dR is less mutagenic than dL in these repair deficient strains. Similarly to dL, no increase in dR-induced reversion rates was detected in the NER-deficient strain.
Table 3. Mutation frequencies from in vivo replication of site-specifically incorporated dR residue into M13G*1 phage DNA.
| Strain (genotype) | Ratio of no. of blue plaques to no. of screened plaques | Mutation frequency | Averagea | Ratio of mutant to WT |
|---|---|---|---|---|
| BH70F′ (WT) | (6.4 ± 3) × 10–5 | 1 | ||
| Ex.1 | 4/57 200 | 7 × 10–5 | ||
| Ex.2 | 1/33 200 | 3 × 10–5 | ||
| Ex.3 | 1/10 900 | 9 × 10–5 | ||
| BH110F′ (xth nfo) | (2.1 ± 0.8) × 10–4 | 3.3 | ||
| Ex.1 | 1/7800 | 1.28 × 10–4 | ||
| Ex.2 | 4/15 600 | 2.56 × 10–4 | ||
| Ex.3 | 26/102 000 | 2.55 × 10–4 | ||
| BH160F′ (nth fpg) | (3.2 ± 1.0) × 10–4 | 5 | ||
| Ex.1 | 10/40 800 | 2.45 × 10–4 | ||
| Ex.2 | 3/10 800 | 2.8 × 10–4 | ||
| Ex.3 | 1/2300 | 4.34 × 10–4 | ||
| JM105 (WT) | (4.7 ± 2.6) × 10–5 | 1 | ||
| Ex.1 | 2/30 000 | 6.66 × 10–5 | ||
| Ex.2 | 17/252 800 | 6.7 × 10–5 | ||
| Ex.3 | 2/48 000 | 4.2 × 10–5 | ||
| Ex.4 | 5/410 000 | 1.2 × 10–5 | ||
| BH430 (uvrA) | 3.0 × 10–5 | 0.6 | ||
| Ex.1 | 0/6240 | 0 | ||
| Ex.2 | 1/32 800 | 3 × 10–5 | ||
| Ex.3 | 0/294 000 | 0 | ||
| BH1100 (recA) | (2.0 ± 0.7) × 10–4 | 4.3 | ||
| Ex.1 | 7/25 000 | 2.8 × 10–4 | ||
| Ex.2 | 2/10 000 | 2 × 10–4 | ||
| Ex.3 | 19/108 000 | 1.8 × 10–4 | ||
| Ex.4 | 4/36 400 | 1 × 10–4 | ||
| Ex.5 | 6/26400 | 2.3 × 10–4 |
aFrequency numbers are the average ± standard deviation of three to five independent experiments.
The synthetic precursor, the dNi nucleotide, is not a natural modification and it has been specially designed to generate dL in DNA under UV irradiation. As shown in Table 4, significant variation in dNi-induced mutation frequencies was detected between non-isogenic BH70F′ and JM105 WT strains (p < 0.01), whereas no significant increase in mutation frequency was observed in BER-deficient mutants compared with the isogenic WT strain. In contrast, a >10-fold increase in reversion rate was observed in the homologous recombination-deficient strain. Surprisingly, there was a very low yield of transformants for dNi-containing phage DNA in the NER-deficient BH430 strain. The number of plaques did not allow determination of the reversion frequency for this mutant.
Analysis of the mutation spectra induced by dL, dNi and dR
The phage DNAs from revertants were sequenced in order to determine the nature and occurrence of mutations resulting from in vivo replication of modified vectors. As shown in Table 5, all mutations were detected at the target site and no other sequence changes were detected within a 200 nt region containing the target site. Since the M13G*1-based reversion assay was designed to detect all base substitutions, except X→G base substitution and frameshifts, the majority of dL, dR and dNi-induced mutations were X→A,C,T mutations. As expected, in 79% of the cases dAMP was introduced opposite to dR, confirming the previous observations (62,63). In contrast, the spectrum of mutations induced by dL and dNi did not obey the ‘A rule’. For dL, TMP was the most frequently incorporated nucleotide (55%) followed by dAMP (18%) and dGMP (12%). A significant number (11%) of two-nucleotide inversions GX→AG (where X is dL) were also observed. On the other hand, both TMP (40%) and dAMP (42%) were preferentially introduced opposite dNi. An inversion GX→TG (3%) and insertion of an extra C accompanied with a T deletion (8%) were also detected for dNi. The difference in mutation spectra obtained for dL and dNi further confirms the photoconversion of dNi to dL within a phage vector.
Table 5. Mutation spectra of the site-specifically incorporated lesions.
| Mutation | Oligo-dL (%) | Oligo-dNi (%) | Oligo-dR (%) |
|---|---|---|---|
| GGXAAATG→GGTAAATG | 18 | 40 | 79 |
| Transversion (G→T) | |||
| GGXAAATG→GGCAAATG | 12 | 4 | 12 |
| Transversion (G→C) | |||
| GGXAAATG→GGAAAATG | 55 | 42 | 9 |
| Transition (G→A) | |||
| GGXAAATG→GAGAAATG | 11 | 1 | 0 |
| Complex mutation (GX→AG) | |||
| GGXAAATG→GTGAAATG | 0 | 3 | 0 |
| Complex mutation (GX→TG) | |||
| GGXAAATG→GGCGAAAG | 3 | 8 | 0 |
| Complex mutation: insertion (C) + deletion (ΔT) | |||
| Other mutations | 1 | 2 | 0 |
| Total mutants sequenced | 84 | 76 | 33 |
DISCUSSION
Free-radical attack and oxidation produce a tremendous multiplicity of DNA modifications in vivo. Consequently, the toxicity and the mutagenic effect of a given lesion are difficult to assess. A variety of efficient and reliable methods have been developed for the construction of site-directed mutations in extra-chromosomal vector DNA using synthetic oligonucleotides with defined lesions in both prokaryotic and eukaryotic cells (64). To incorporate the very unstable dL lesion, which is 20 times less stable than dR at 37°C (20), we chose a strategy, described by Cheng et al. (57) for an unstable exocyclic guanine adduct, based on the site-directed incorporation of a lesion into the double-stranded M13mp2-derived bacteriophage vector M13G*1. This approach allows the incorporation of dNi and dU (the stable precursors of dL and dR, respectively) following conversion to the baseless lesions and immediate transformation into cells.
Currently, very little is known about repair mechanisms of dL in E.coli. Previous studies have shown that dL is a substrate for some AP endonucleases (32, and our unpublished results) and DNA glycosylases/AP lyases (33). Conversely, the repair of dR in E.coli is well studied. Various overlapping repair pathways including AP endonucleases Xth and Nfo (65), DNA glycosylases/AP lyases Fpg and Nth (66,67), the UvrABC complex, which is central in the NER pathway (68) and the RecA protein, which is central in recombination and translesion DNA synthesis (69), are involved in dR repair. In the present study, we used the M13G*1 reversion assay to explore the importance of AP endonucleases, DNA glycosylases, the NER pathway and homologous recombination in the handling of dL sites in E.coli. In addition, the repair of dR and dNi was also investigated.
Under the illumination conditions used, ≥90% of dNi was converted into dL. Importantly, the UV irradiation of non-modified M13*G1 did not induce mutations. The mutation frequencies for the site-specifically incorporated dL nucleoside in WT E.coli strains were low [(5.5–5.7) × 10–5] compared with mismatched dC (4 × 10–1). The presence of dL in the (–) strand may lead to replication bias towards non-damaged (+) DNA strand in vivo and therefore mask the mutagenic effect of the lesion. However, using altered site mutagenesis we have shown that replication bias towards non-damaged (+) strand was not significant. Interestingly, the mutation frequencies for dR [(3.0–6.4) × 10–5] and dNi [(14.0–2.2) × 10–5] in WT E.coli strains were also low, suggesting that these modified residues are not highly mutagenic. However, low mutagenesis could also be due to efficient repair of dR, dL and dNi. Indeed, we showed that in the xth nfo strain the dL-induced mutation frequency increased ≥30-fold compared with WT. This result strongly suggests that in E.coli the AP endonucleases play a major role in the removal of dL. In contrast, either slight or no increase in dL-induced reversion frequency were observed in recA, fpg nth and uvrA strains as compared with WT strain suggesting that the oxidized AP sites are not substrates for AP lyases, homologous recombination and NER in vivo.
AP endonuclease deficient E.coli strain has a weak spontaneous mutator phenotype suggesting that dR residues are not highly mutagenic in vivo (65). In agreement with this observation, we found only a 3-fold increase of dR-induced reversions in E.coli xth nfo mutant. This is at variance with the 30-fold increase observed with dL, implying that the oxidized AP site might be more mutagenic than dR if not repaired. In vitro the Fpg and Nth proteins can cleave dR via β-elimination with high efficiency (66,67) and may participate in repair of AP sites. However, it was shown that fpg and nth, in contrast with xth and xth nfo mutants, are not sensitive to alkylation DNA damage, suggesting that DNA glycosylases/AP lyases play a minor role in repair of AP sites in vivo (70,71). Interestingly, we found a significant 5-fold increase of dR-induced reversion frequency in E.coli fpg nth mutant, suggesting that the DNA glycosylases/AP lyases suppress mutations induced by dR in vivo. It was also shown that in E.coli, AP site-directed mutagenesis requires activation of the SOS response system (72). This damage-inducible pathway involves the RecA-dependent induction of the error-prone DNA polymerases that lack exonuclease proofreading ability. Such polymerases are more capable of bypassing an AP site in vitro than polymerases of high fidelity (73). However, it has recently been shown that RecA also participates in error-free recombinational repair which predominates over mutagenic translesion replication (74). We found a 4-fold increase of dR-induced reversion frequency in E.coli recA mutant, suggesting that in non-induced cells RecA participates in error-free repair of dR residues.
Since dNi is a non-natural nucleoside, it may not be recognized by excision repair in E.coli. Indeed, no significant increase in dNi-induced mutation frequencies was observed in BER-deficient mutants compared with isogenic corresponding WT E.coli strains. Because of the very low yield of transformants in BH430 strain, nothing can be said about the role of NER in dNi-induced mutagenesis. However, we speculate that replication of dNi-containing phage may depend on NER function. Similarly to dR, a 10-fold increase in dNi-induced reversion rate was found in E.coli recA mutant, suggesting that RecA may participate either in non-mutagenic DNA translesion synthesis (TLS) or in the removal of dNi.
The mutagenic consequences of replicating M13 DNA containing dL, dR or dNi nucleotides were examined. Despite structural similarity between dL and dR, the ‘A rule’ (47,48) was not respected for either dL or dNi. We detected preferential incorporation of TMP opposite to dL, whereas TMP and dAMP were incorporated with the same insertion frequency opposite to dNi. Furthermore, in addition to base substitution, dL and dNi induced complex mutations which were combinations of deletion and insertion. Importantly, the presence of residual dNi in irradiated phage DNA cannot be considered to have a significant contribution to the dL-induced mutation spectrum. As shown in Table 5, the ‘complex mutations’ for these two lesions show a completely different distribution. They represent 13% of the total for dNi in 76 sequenced clones versus 4% for dL in 84 sequenced clones. Both dL and dNi preferentially induce X→A base substitution and complex mutations, implying that translesional synthesis machinery does not discriminate these structurally different lesions efficiently. On the other hand, AP endonucleases recognize dL but not dNi. A structural study by high-field NMR spectroscopy is in progress to determine the geometry of dNi pairing with natural bases.
Previously, we demonstrated a neat preferential incorporation of dAMP opposite dL and dNi in vitro: by Klenow fragment DNA polymerase I devoid of 3′ exonucleolytic activity (KF exo–) (51). In contrast, in vivo we have found preferential incorporation of TMP opposite to dL and dNi. We propose that discrepancies between in vivo and in vitro mutagenesis might be due to several factors: First, it was shown that the chemical structure of a lesion is not the only determinant of the spectra and efficiency of mutagenesis (75–77). Indeed, the neighboring sequences used for in vitro studies (5′-AXG-3′) and in the present work (5′-GXA-3′) were different. Importantly, in vitro replication performed on short pieces of DNA may give rise in some cases to sequence-dependent results due to a realignment process in the primer–matrix duplex. Secondly, the nature of DNA polymerases involved in TLS may influence mutational spectra. It has been postulated that in eukaryotes TLS is a ‘two-polymerase affair’ involving an ‘inserter polymerase’ and an ‘extender polymerase’ (78). In E.coli, polymerase V could relieve a stalled polymerase III holoenzyme at the lesion site and extend primer 3′ ends, suggesting that prokaryotic TLS might be also catalyzed by two polymerases (73). Thirdly, the interactions between lesion and cellular proteins might affect TLS. Recently it has been demonstrated that dL may cross-link with E.coli Nth and human polymerase β, indicating that dL reactivity towards cellular proteins may have also important consequences on repair and mutagenesis (33,79).
In conclusion, in the present study, we have demonstrated that dL is as mutagenic as the AP site in non-induced E.coli. Despite their structural analogy, repair pathways for dL and dR are not similar. In vivo the dL lesion is processed by the AP endonucleases Xth and Nfo which are involved in abasic lesion repair. Unlike dR, the dL residue is a rather poor substrate for Fpg, Nth and recombinational repair. The absence of an increase of mutagenesis in uvrA mutant strongly suggests that dL is not a substrate for NER pathway. Finally, the most common mutagenic response to the presence of dL is the incorporation of TMP. These results show that a small difference in the DNA lesion structure can have tremendous effect on repair and mutagenesis.
Acknowledgments
ACKNOWLEDGEMENTS
We thank Dr Jacques Laval for his interest in this work. We wish to thank Dr Thomas Reid and Dr Lawrence A. Loeb for the M13G*1 bacteriophage vector, Dr Mitsuaru Kotera for the dNi phosphoramidite and Elisabeth Loire for technical assistance. We also thank Professor Marc Greenberg for sharing results prior to publication. This research was supported by European Community Grant RISC-RAD FI6R-CT-2003–508842 (M.S.), Association pour la Recherche sur le Cancer (M.S.) and Electricité de France Contrat Radioprotection RB 2004–02 (M.S.) and RB 2003–28 (J.-F.C and P.D.).
REFERENCES
- 1.Pogozelski W.K. and Tullius,T.D. (1998) Oxidative strand scission of nucleic acids: routes initiated by hydrogen abstraction from the sugar moiety. Chem. Rev., 98, 1089–1107. [DOI] [PubMed] [Google Scholar]
- 2.Dedon P.C. and Goldberg,I.H. (1992) Free-radical mechanisms involved in the formation of sequence-dependent bistranded DNA lesions by the antitumor antibiotics bleomycin, neocarzinostatin and calicheamicin. Chem. Res. Toxicol., 5, 311–332. [DOI] [PubMed] [Google Scholar]
- 3.Kappen L.S. and Goldberg,I.H. (1989) Identification of 2-deoxyribonolactone at the site of neocarzinostatin-induced cytosine release in the sequence d(AGC). Biochemistry, 28, 1027–1032. [DOI] [PubMed] [Google Scholar]
- 4.Kappen L.S., Chen,C.Q. and Goldberg,I.H. (1988) Atypical abasic sites generated by neocarzinostatin at sequence-specific cytidylate residues in oligodeoxynucleotides. Biochemistry, 27, 4331–4340. [DOI] [PubMed] [Google Scholar]
- 5.Goldberg I.H. (1991) Mechanism of neocarzinostatin action: role of DNA microstructure in determination of chemistry of bistranded oxidative damage. Acc. Chem. Res., 24, 191–198. [Google Scholar]
- 6.Daniels J.S., Gates,K.S., Tronche,C. and Greenberg,M.M. (1998) Direct evidence for bimodal DNA damage induced by tirapazamine. Chem. Res. Toxicol., 11, 1254–1257. [DOI] [PubMed] [Google Scholar]
- 7.Ban F., Gauld,J.W. and Boyd,R.J. (2001) Modeling the action of an antitumor drug: a density functional theory study of the mechanism of tirapazamine. J. Am. Chem. Soc., 123, 7320–7325. [DOI] [PubMed] [Google Scholar]
- 8.Pratviel G., Pitie,M., Bernadou,J. and Meunier,B. (1991) Mechanism of DNA cleavage by cationic manganese porphyrins: hydroxylations at the 1′-carbon and 5′-carbon atoms of deoxyriboses as initial damages. Nucleic Acids Res., 19, 6283–6288. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Pratviel G., Bernadou,J. and Meunier,B. (1995) Carbon–hydrogen bonds of DNA sugar units as targets for chemical nucleases and drugs. Angew. Chem. Int. Ed. Engl., 34, 746–769. [Google Scholar]
- 10.Goyne T.E. and Sigman,D.S. (1987) Nuclease activity of 1,10-phenanthroline-copper ion. Chemistry of deoxyribose oxidation. J. Am. Chem. Soc., 109, 2846–2848. [Google Scholar]
- 11.Chen T. and Greenberg,M.M. (1998) Model studies indicate that copper phenanthroline induces direct strand breaks via β-elimination of the 2′-deoxyribonolactone intermediate observed in enediyne mediated DNA damage. J. Am. Chem. Soc., 120, 3815–3816. [Google Scholar]
- 12.Sigman D.S., Mazumder,A. and Perrin,D.M. (1993) Chemical nucleases. Chem. Rev., 93, 2295–2316. [Google Scholar]
- 13.Shaw A.A. and Cadet,J. (1996) Direct effects of γ-radiation on 2′-deoxycytidine in frozen aqueous solution. Int. J. Radiat. Biol., 70, 1–6. [DOI] [PubMed] [Google Scholar]
- 14.von Sonntag C. (1991) The chemistry of free-radical-mediated DNA damage. Basic Life Sci., 58, 287–317. [DOI] [PubMed] [Google Scholar]
- 15.Urata H., Yamamoto,K., Akagi,M., Hiroaki,H. and Uesugi,S. (1989) A 2-deoxyribonolactone-containing nucleotide: isolation and characterization of the alkali-sensitive photoproduct of the trideoxyribonucleotide d(ApCpA). Biochemistry, 28, 9566–9569. [DOI] [PubMed] [Google Scholar]
- 16.Urata H. and Akagi,M. (1991) Photo-induced formation of the 2-deoxyribonolactone-containing nucleotide for d(ApCpA); effects of neighboring bases and modification of deoxycytidine. Nucleic Acids Res., 19, 1773–1778. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Cadet J., Delatour,T., Douki,T., Gasparutto,D., Pouget,J.P., Ravanat,J.L. and Sauvaigo,S. (1999) Hydroxyl radicals and DNA base damage. Mutat. Res., 424, 9–21. [DOI] [PubMed] [Google Scholar]
- 18.Meijler M.M., Zelenko,O. and Sigman,D.S. (1997) Chemical mechanism of DNA scission by (1,10-phenanthroline)copper. Carbonyl oxygen of 5-methylenefuranone is derived from water. J. Am. Chem. Soc., 119, 1135–1136. [Google Scholar]
- 19.Hwang J.T., Tallman,K.A. and Greenberg,M.M. (1999) The reactivity of the 2-deoxyribonolactone lesion in single-stranded DNA and its implication in reaction mechanisms of DNA damage and repair. Nucleic Acids Res., 27, 3805–3810. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Roupioz Y., Kotera,M. and Lhomme,J. (2002) Chemistry of the 2-deoxyribonolactone lesion in oligonucleotides: cleavage kinetics and products analysis. J. Am. Chem. Soc., 124, 9129–9135. [DOI] [PubMed] [Google Scholar]
- 21.Zelenko O., Gallager,J. and Sigman,D.S. (1997) Scission of DNA with bis(1,10-phenanthroline)copper without intramolecular hydrogen migration. Angew. Chem. Int. Ed. Engl., 36, 2776–2778. [Google Scholar]
- 22.Oyoshi T. and Sugiyama,H. (2000) Mechanism of DNA strand scission induced by (1,10-phenanthroline)copper complex: major direct DNA cleavage is not through 1′,2′-dehydronucleotide intermediate nor beta-elimination of forming ribonolactone. J. Am. Chem. Soc., 122, 6313–6314. [Google Scholar]
- 23.Bose R.N., Fonkeng,B.S., Moghaddas,S. and Stroup,D. (1998) Mechanisms of DNA damage by chromium(V) carcinogens. Nucleic Acids Res., 27, 1588–1596. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Kotera M., Bourdat,A.-G., Defrancq,E. and Lhomme,J. (1998) A highly efficient synthesis of oligodeoxyribonucleotides containing the 2′-deoxyribonolactone lesion. J. Am. Chem. Soc., 120, 11810–11811. [Google Scholar]
- 25.Jourdan M., Garcia,J., Defrancq,E., Kotera,M. and Lhomme,J. (1999) 2′-Deoxyribonolactone lesion in DNA: refined solution structure determined by nuclear magnetic resonance and molecular modeling. Biochemistry, 38, 3985–3995. [DOI] [PubMed] [Google Scholar]
- 26.Buchko G.W. and Cadet,J. (1992) Identification of 2-deoxy-d-ribono-1,4-lactone at the site of benzophenone photosensitized release of guanine in 2′-deoxyguanosine and thymidylyl-(3′-5′)-deoxyguanosine. Can. J. Chem., 70, 1827–1832. [Google Scholar]
- 27.Sugiyama H., Hosoda,M. and Saito,I. (1990) Covalent alkylation of DNA with duocarmycin A. Identification of the abasic site structure. Tetrahedron Lett., 31, 7197–7200. [PubMed] [Google Scholar]
- 28.Sugiyama H., Tsutsumi,Y., Fujimoto,K. and Saito,I. (1993) Photoinduced deoxyribose C2′-oxidation in DNA. Alkali-dependent cleavage of erythrose-containing sites via a retroaldol reaction. J. Am. Chem. Soc., 115, 4443–4448. [Google Scholar]
- 29.Sugiyama H., Fujimoto,K. and Saito,I. (1995) Stereospecific 1,2-hydride shift in ribonolactone formation in the photoreaction of 2′-iododeoxyuridine. J. Am. Chem. Soc., 117, 2945–2946. [Google Scholar]
- 30.Goodman B.K. and Greenberg,M.M. (1996) Independent generation and reactivity of 2′-deoxyurid-1′-yl. J. Org. Chem., 61, 2–3. [Google Scholar]
- 31.Chatgilialoglu C. and Gimisis,T. (1998) Fate of the C-1′ peroxyl radical in the 2′-deoxyuridine system. Chem. Commun., 1249–1250. [Google Scholar]
- 32.Xu Y.J., DeMott,M.S., Hwang,J.T., Greenberg,M.M. and Demple,B. (2003) Action of human apurinic endonuclease (Ape1) on C1′-oxidized deoxyribose damage in DNA. DNA Repair, 2, 175–185. [DOI] [PubMed] [Google Scholar]
- 33.Hashimoto M., Greenberg,M.M., Kow,Y.W., Hwang,J.T. and Cunningham,R.P. (2001) The 2-deoxyribonolactone lesion produced in DNA by neocarzinostatin and other damaging agents forms cross-links with the base-excision repair enzyme endonuclease III. J. Am. Chem. Soc., 123, 3161–3162. [DOI] [PubMed] [Google Scholar]
- 34.Kroeger K.M., Hashimoto,M., Kow,Y.W. and Greenberg,M.M. (2003) Cross-linking of 2-deoxyribonolactone and its beta-elimination product by base excision repair enzymes. Biochemistry, 42, 2449–2455. [DOI] [PubMed] [Google Scholar]
- 35.Lenox H.J., McCoy,C.P. and Sheppard,T.L. (2001) Site-specific generation of deoxyribonolactone lesions in DNA oligonucleotides. Org. Lett., 3, 2415–2418. [DOI] [PubMed] [Google Scholar]
- 36.Lindahl T. (2001) Keynote: past, present and future aspects of base excision repair. Prog. Nucleic Acid Res. Mol. Biol., 68, 27–30. [DOI] [PubMed] [Google Scholar]
- 37.Gros L., Saparbaev,M.K. and Laval,J. (2002) Enzymology of the repair of free radical-induced DNA damage. Oncogene, 21, 8905–8925. [DOI] [PubMed] [Google Scholar]
- 38.Taylor A.F. and Weiss,B. (1982) Role of exonuclease III in the base excision repair of uracil-containing DNA. J. Bacteriol., 151, 351–357. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Wilson D.M. 3rd and Barsky,D. (2001) The major human abasic endonuclease: formation, consequences and repair of abasic lesions in DNA. Mutat. Res., 485, 283–307. [DOI] [PubMed] [Google Scholar]
- 40.Gentil A., Cabral-Neto,J.B., Mariage-Samson,R., Margot,A., Imbach,J.L., Rayner,B. and Sarasin,A. (1992) Mutagenicity of a unique apurinic/apyrimidinic site in mammalian cells. J. Mol. Biol., 227, 981–984. [DOI] [PubMed] [Google Scholar]
- 41.Ide H., Murayama,H., Sakamoto,S., Makino,K., Honda,K., Nakamuta,H., Sasaki,M. and Sugimoto,N. (1995) On the mechanism of preferential incorporation of dAMP at abasic sites in translesional DNA synthesis. Role of proofreading activity of DNA polymerase and thermodynamic characterization of model template-primers containing an abasic site. Nucleic Acids Res., 23, 123–129. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Hatahet Z., Zhou,M., Reha-Krantz,L.J., Ide,H., Morrical,S.W. and Wallace,S.S. (1999) In vitro selection of sequence contexts which enhance bypass of abasic sites and tetrahydrofuran by T4 DNA polymerase holoenzyme. J. Mol. Biol., 286, 1045–1057. [DOI] [PubMed] [Google Scholar]
- 43.Zhou W. and Doetsch,P.W. (1994) Efficient bypass and base misinsertions at abasic sites by prokaryotic RNA polymerases. Ann. N. Y. Acad. Sci., 726, 351–354. [DOI] [PubMed] [Google Scholar]
- 44.Rogers S.G. and Weiss,B. (1980) Exonuclease III of Escherichia coli K-12, an AP endonuclease. Methods Enzymol., 65, 201–211. [DOI] [PubMed] [Google Scholar]
- 45.Chan E. and Weiss,B. (1987) Endonuclease IV of Escherichia coli is induced by paraquat. Proc. Natl Acad. Sci. USA, 84, 3189–3193. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46.Ljungquist S. (1977) A new endonuclease from Escherichia coli acting at apurinic sites in DNA. J. Biol. Chem., 252, 2808–2814. [PubMed] [Google Scholar]
- 47.Strauss B.S. (1991) The ‘A rule’ of mutagen specificity: a consequence of DNA polymerase bypass of non-instructional lesions? Bioessays, 13, 79–84. [DOI] [PubMed] [Google Scholar]
- 48.Boiteux S. and Laval,J. (1982) Coding properties of poly(deoxycytidylic acid) templates containing uracil or apyrimidinic sites: in vitro modulation of mutagenesis by deoxyribonucleic acid repair enzymes. Biochemistry, 21, 6746–6751. [DOI] [PubMed] [Google Scholar]
- 49.Cabral Neto J.B., Cabral,R.E., Margot,A., Le Page,F., Sarasin,A. and Gentil,A. (1994) Coding properties of a unique apurinic/apyrimidinic site replicated in mammalian cells. J. Mol. Biol., 240, 416–420. [DOI] [PubMed] [Google Scholar]
- 50.Avkin S., Adar,S., Blander,G. and Livneh,Z. (2002) Quantitative measurement of translesion replication in human cells: evidence for bypass of abasic sites by a replicative DNA polymerase. Proc. Natl Acad. Sci. USA, 99, 3764–3769. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 51.Berthet N., Roupioz,Y., Constant,J.-F., Kotera,M. and Lhomme,J. (2001) Translesional synthesis on DNA templates containing the 2′-deoxyribonolactone lesion. Nucleic Acids Res., 29, 2725–2732. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 52.Miller J.H. (1992) A Short Course in Bacterial Genetics. A Laboratory Manual and Handbook for Escherichia Coli and Related Bacteria. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY. [Google Scholar]
- 53.Sambrook J., Fitsch,E.F. and Maniatis,T. (1989) Molecular Cloning: A Laboratory Manual. 2nd edn. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY. [Google Scholar]
- 54.Dower W.J., Miller,J.F. and Ragsdale,C.W. (1988) High efficiency transformation of E.coli by high voltage electroporation. Nucleic Acids Res., 16, 6127–6145. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 55.Singer M., Baker,T.A., Schnitzler,G., Deischel,S.M., Goel,M., Dove,W., Jaacks,K.J., Grossman,A.D., Erickson,J.W. and Gross,C.A. (1989) A collection of strains containing genetically linked alternating antibiotic resistance elements for genetic mapping of Escherichia coli. Microbiol. Rev., 53, 1–24. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 56.Summers D.K. and Withers,H.L. (1990) Electrotransfer: direct transfer of bacterial plasmid DNA by electroporation. Nucleic Acids Res., 18, 2192. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 57.Cheng K.C., Preston,B.D., Cahill,D.S., Dosanjh,M.K., Singer,B. and Loeb,L.A. (1991) The vinyl chloride DNA derivative N2,3-ethenoguanine produces G–A transitions in Escherichia coli. Proc. Natl Acad. Sci. USA, 88, 9974–9978. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 58.Saparbaev M., Langouet,S., Privezentzev,C.V., Guengerich,F.P., Cai,H., Elder,R.H. and Laval,J. (2002) 1,N(2)-ethenoguanine, a mutagenic DNA adduct, is a primary substrate of Escherichia coli mismatch-specific uracil–DNA glycosylase and human alkylpurine-DNA-N-glycosylase. J. Biol. Chem., 277, 26987–26993. [DOI] [PubMed] [Google Scholar]
- 59.Yuckenberg P.D., Witney,F., Geisselsoder,J. and McClary,J. (1991) Site-directed in vitro mutagenesis using uracil-containing DNA and phagemid vectors. In McPherson,M.J. (ed.), Directed Mutagenesis: A Practical Approach. Oxford University Press, Oxford, pp. 36–39. [Google Scholar]
- 60.Kerins S.M., Collins,R. and McCarthy,T.V. (2003) Characterization of an endonuclease IV 3′-5′ exonuclease activity. J. Biol. Chem., 278, 3048–3054. [DOI] [PubMed] [Google Scholar]
- 61.Sedlacek J., Fabry,M. and Smrt,J. (1987) Design of synthetic oligonucleotide duplexes for site-directed mutagenesis with recombinant plasmids. Nucleic Acids Symp. Ser., 245–248. [PubMed] [Google Scholar]
- 62.Shibutani S., Takeshita,M. and Grollman,A.P. (1997) Translesional synthesis on DNA templates containing a single abasic site. A mechanistic study of the ‘A rule’. J. Biol. Chem., 272, 13916–13922. [DOI] [PubMed] [Google Scholar]
- 63.Lawrence C.W., Borden,A., Banerjee,S.K. and LeClerc,J.E. (1990) Mutation frequency and spectrum resulting from a single abasic site in a single-stranded vector. Nucleic Acids Res., 18, 2153–2157. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 64.Wang D., Kreutzer,D.A. and Essigmann,J.M. (1998) Mutagenicity and repair of oxidative DNA damage: insights from studies using defined lesions. Mutat. Res., 400, 99–115. [DOI] [PubMed] [Google Scholar]
- 65.Cunningham R.P., Saporito,S.M., Spitzer,S.G. and Weiss,B. (1986) Endonuclease IV (nfo) mutant of Escherichia coli. J. Bacteriol., 168, 1120–1127. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 66.O’Connor T.R. and Laval,J. (1989) Physical association of the 2,6-diamino-4-hydroxy-5N-formamidopyrimidine-DNA glycosylase of Escherichia coli and an activity nicking DNA at apurinic/apyrimidinic sites. Proc. Natl Acad. Sci. USA, 86, 5222–5226. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 67.Kim J. and Linn,S. (1988) The mechanisms of action of E.coli endonuclease III and T4 UV endonuclease (endonuclease V) at AP sites. Nucleic Acids Res., 16, 1135–1141. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 68.Snowden A., Kow,Y.W. and Van Houten,B. (1990) Damage repertoire of the Escherichia coli UvrABC nuclease complex includes abasic sites, base-damage analogues and lesions containing adjacent 5′ or 3′ nicks. Biochemistry, 29, 7251–7259. [DOI] [PubMed] [Google Scholar]
- 69.Otterlei M., Kavli,B., Standal,R., Skjelbred,C., Bharati,S. and Krokan,H.E. (2000) Repair of chromosomal abasic sites in vivo involves at least three different repair pathways. EMBO J., 19, 5542–5551. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 70.Boiteux S. and Huisman,O. (1989) Isolation of a formamidopyrimidine-DNA glycosylase (fpg) mutant of Escherichia coli K12. Mol. Gen. Genet., 215, 300–305. [DOI] [PubMed] [Google Scholar]
- 71.Eide L., Fosberg,E., Hoff,E. and Seeberg,E. (2001) Overexpression of endonuclease III protects Escherichia coli mutants defective in alkylation repair against lethal effects of methylmethanesulphonate. FEBS Lett., 491, 59–62. [DOI] [PubMed] [Google Scholar]
- 72.Schaaper R.M. and Loeb,L.A. (1981) Depurination causes mutations in SOS-induced cells. Proc. Natl Acad. Sci. USA, 78, 1773–1777. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 73.Tang M., Pham,P., Shen,X., Taylor,J.S., O’Donnell,M., Woodgate,R. and Goodman,M.F. (2000) Roles of E.coli DNA polymerases IV and V in lesion-targeted and untargeted SOS mutagenesis. Nature, 404, 1014–1018. [DOI] [PubMed] [Google Scholar]
- 74.Berdichevsky A., Izhar,L. and Livneh,Z. (2002) Error-free recombinational repair predominates over mutagenic translesion replication in E.coli. Mol. Cell, 10, 917–924. [DOI] [PubMed] [Google Scholar]
- 75.Litinski V., Chenna,A., Sagi,J. and Singer,B. (1997) Sequence context is an important determinant in the mutagenic potential of 1,N6-ethenodeoxyadenosine (epsilonA): formation of epsilonA basepairs and elongation in defined templates. Carcinogenesis, 18, 1609–1615. [DOI] [PubMed] [Google Scholar]
- 76.Kozack R., Seo,K.Y., Jelinsky,S.A. and Loechler,E.L. (2000) Toward an understanding of the role of DNA adduct conformation in defining mutagenic mechanism based on studies of the major adduct (formed at N(2)-dG) of the potent environmental carcinogen, benzo[a]pyrene. Mutat. Res., 450, 41–59. [DOI] [PubMed] [Google Scholar]
- 77.Shimizu H., Yagi,R., Kimura,Y., Makino,K., Terato,H., Ohyama,Y. and Ide,H. (1997) Replication bypass and mutagenic effect of alpha-deoxyadenosine site-specifically incorporated into single-stranded vectors. Nucleic Acids Res., 25, 597–603. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 78.Prakash S. and Prakash,L. (2002) Translesion DNA synthesis in eukaryotes: a one- or two-polymerase affair. Genes Dev., 16, 1872–1883. [DOI] [PubMed] [Google Scholar]
- 79.DeMott M.S., Beyret,E., Wong,D., Bales,B.C., Hwang,J.T., Greenberg,M.M. and Demple,B. (2002) Covalent trapping of human DNA polymerase beta by the oxidative DNA lesion 2-deoxyribonolactone. J. Biol. Chem., 277, 7637–7640. [DOI] [PubMed] [Google Scholar]


